ImportRefusal LogoImportRefusal

Unique Pharmaceutical Laboratories (A Div. of JB Chemicals & Pharmaceuticals Ltd)

⚠️ High Risk

FEI: 3003647459 • Daman, Dadra and Nagar Haveli and Dam • INDIA

FEI

FEI Number

3003647459

📍

Location

Daman, Dadra and Nagar Haveli and Dam

🇮🇳

Country

INDIA
🏢

Address

Survey No.101/2 & 102/1, Daman Industrial Estate, Airport Road, , Kadaiya, Daman, Dadra and Nagar Haveli and Dam, India

High Risk

FDA Import Risk Assessment

60.7
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

11
Total Refusals
6
Unique Violations
11/13/2025
Latest Refusal
10/30/2009
Earliest Refusal

Score Breakdown

Violation Severity
71.8×40%
Refusal Volume
40.0×30%
Recency
96.4×20%
Frequency
6.8×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

759×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

112×

UNSAFE COL

The article appears to be, or to bear or contain a color additive which is unsafe within the meaning of Section 721(a).

1182×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

32602×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 801.15(c)(1)

4721×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).

4731×

LABELING

The article appears in violation of FPLA because of its placement, form and/or contents statement.

Refusal History

DateProductViolationsDivision
11/13/2025
62ODA09TELMISARTAN (ANTI-HYPERTENSIVE - PART II)
75UNAPPROVED
Division of Northeast Imports (DNEI)
10/9/2025
66VCA99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/20/2025
66VDY99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/14/2025
62CCB99ANTI-HYPERTENSIVE N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/7/2023
66VBY99MISCELLANEOUS PATENT MEDICINES, ETC.
11UNSAFE COL
3260NO ENGLISH
75UNAPPROVED
Division of Northeast Imports (DNEI)
9/7/2023
66VBY99MISCELLANEOUS PATENT MEDICINES, ETC.
11UNSAFE COL
3260NO ENGLISH
75UNAPPROVED
Division of Northeast Imports (DNEI)
9/30/2018
60SCA28RANITIDINE (ANTACID)
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/30/2013
61CDR01LEUCOVORIN CALCIUM (ANTI-ANEMIC)
75UNAPPROVED
Los Angeles District Office (LOS-DO)
1/30/2013
61CDR01LEUCOVORIN CALCIUM (ANTI-ANEMIC)
75UNAPPROVED
Los Angeles District Office (LOS-DO)
7/9/2011
61LBK14CHLORHEXIDINE GLUCONATE
473LABELING
New York District Office (NYK-DO)
10/30/2009
62LDJ40METRONIDAZOLE (ANTI-PROTOZOAL, A-LEISHMANIAL, A-MALARIAL)
472NO ENGLISH
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Unique Pharmaceutical Laboratories (A Div. of JB Chemicals & Pharmaceuticals Ltd)'s FDA import refusal history?

Unique Pharmaceutical Laboratories (A Div. of JB Chemicals & Pharmaceuticals Ltd) (FEI: 3003647459) has 11 FDA import refusal record(s) in our database, spanning from 10/30/2009 to 11/13/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Unique Pharmaceutical Laboratories (A Div. of JB Chemicals & Pharmaceuticals Ltd)'s FEI number is 3003647459.

What types of violations has Unique Pharmaceutical Laboratories (A Div. of JB Chemicals & Pharmaceuticals Ltd) received?

Unique Pharmaceutical Laboratories (A Div. of JB Chemicals & Pharmaceuticals Ltd) has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Unique Pharmaceutical Laboratories (A Div. of JB Chemicals & Pharmaceuticals Ltd) come from?

All FDA import refusal data for Unique Pharmaceutical Laboratories (A Div. of JB Chemicals & Pharmaceuticals Ltd) is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.